Tuberculosis (TB) is a significant cause of illness and death worldwide. Immunotherapy has
been investigated in the treatment of TB. The purpose of this study was to perform a meta …

Background Some authorities have advocated Mycobacterium vaccae immunotherapy for
treating tuberculosis and other infections caused by mycobacteria. Objectives To evaluate …

A number of studies have suggested that the Mycobacterium vaccae (MV) vaccine as an
adjunctive therapy has a positive effect in the treatment of multidrug‑resistant tuberculosis …

BACKGROUND: Mycobacterium vaccae, an envionmental saprophyte, has immunogenic
properties that enhance the host immune response. Immunotherapy with M vaccae. has …

OBJECTIVE: To evaluate the effectiveness and safety of Mycobacterium vaccae (MV) in
prevention of tuberculosis (TB) among high risk people. METHODS: Database of MEDLINE …

Objective To evaluate the effect and safety of Mycobacterium vaccae vaccine (M. vaccae
vaccine) on initially treated pulmonary tuberculosis. Methods 342 cases of initially treated …

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations
infected with Mycobacterium tuberculosis (M. tb) and/or HIV for effective TB control …

Objective To evaluate the effectiveness and safety of heat-killed M. vaccae added to
chemotherapy of never-treated tuberculosis (TB) patients. Methods The databases of …

Objective Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an
unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed …

Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world's deadliest bacterial
infection, resulting in more than 1.4 million deaths annually. The emergence of drug …